 SAN DIEGO, April 16, 2021 PRNewswire -- Neurocrine Biosciences, Inc. Nasdaq: NBIX today announced the appointment of Johanna Mercier to its Board of Directors. Ms. Mercier is the Chief Commercial Officer of Gilead Sciences, with responsibility for the global commercialization of Gileads medicines. 